Aberdeen Asset Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $58.9M | Buy |
1,737,470
+118,894
| +7% | +$4.03M | 0.2% | 92 |
|
|
2017
Q1 | $47M | Buy |
1,618,576
+369,908
| +30% | +$10.7M | 0.17% | 110 |
|
|
2016
Q4 | $41M | Buy |
1,248,668
+252,634
| +25% | +$8.3M | 0.16% | 123 |
|
|
2016
Q3 | $31.4M | Buy |
996,034
+271,016
| +37% | +$8.55M | 0.11% | 145 |
|
|
2016
Q2 | $20.4M | Buy |
725,018
+242,766
| +50% | +$6.83M | 0.08% | 204 |
|
|
2016
Q1 | $17.5M | Buy |
482,252
+139,526
| +41% | +$5.07M | 0.06% | 208 |
|
|
2015
Q4 | $10.3M | Buy |
342,726
+69,026
| +25% | +$2.08M | 0.04% | 289 |
|
|
2015
Q3 | $7.8M | Buy |
273,700
+1,800
| +0.7% | +$51.3K | 0.03% | 304 |
|
|
2015
Q2 | $8.96M | Buy |
271,900
+110,100
| +68% | +$3.63M | 0.03% | 285 |
|
|
2015
Q1 | $4.65M | Buy |
161,800
+25,900
| +19% | +$745K | 0.01% | 393 |
|
|
2014
Q4 | $3.7M | Buy |
135,900
+1,600
| +1% | +$43.6K | 0.01% | 437 |
|
|
2014
Q3 | $2.86M | Buy |
134,300
+27,100
| +25% | +$578K | 0.01% | 555 |
|
|
2014
Q2 | $2.41M | Buy |
+107,200
| New | +$2.41M | 0.01% | 613 |
|